SCHEMBL21574914

SCHEMBL21574914

NC(Cc1ccc(OCOP(=O)(O)O)c(O)c1)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC7A5 Q01650 5/20 0.56
▸ PTGS1 P23219 2/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ USP2 O75604 1/20 0.56
▸ EGFR P00533 1/20 0.56
▸ LCK P06239 1/20 0.56
▸ FYN P06241 1/20 0.56
▸ ADORA3 P0DMS8 1/20 0.56
▸ ALOX15 P16050 1/20 0.56
▸ HTR2A P28223 1/20 0.56
▸ PTGS2 P35354 1/20 0.56
▸ RECQL P46063 1/20 0.56
▸ HIF1A Q16665 1/20 0.56
▸ HSD17B10 Q99714 1/20 0.56
▸ TDP1 Q9NUW8 1/20 0.56
▸ NR1I2 O75469 1/20 0.46
▸ PPARG P37231 1/20 0.46
▸ AGTR2 P50052 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ BLM P54132 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17693640 1.00 SLC7A5 (0.56) SLC7A5PTGS1KDM4EUSP2EGFR
SCHEMBL17693598 0.90 ALOX15 (0.43) SLC7A5PTGS1KDM4EUSP2EGFR
SCHEMBL20921973 0.90 SLC7A5 (0.56) SLC7A5PTGS1KDM4EUSP2EGFR
SCHEMBL17693637 0.90 SLC7A5 (0.56) SLC7A5PTGS1KDM4EUSP2EGFR
SCHEMBL17685887 0.87 ALDH1A1 (0.48) SLC7A5PTGS1KDM4EUSP2EGFR
SCHEMBL17685888 0.87 ALDH1A1 (0.48) SLC7A5PTGS1KDM4EUSP2EGFR
Foslevodopa SCHEMBL17685900 0.84 SLC7A5 (0.61) SLC7A5PTGS1KDM4EUSP2EGFR
Foslevodopa SCHEMBL29927312 0.84 SLC7A5 (0.61) SLC7A5PTGS1KDM4EUSP2EGFR
Foslevodopa SCHEMBL17685899 0.84 SLC7A5 (0.61) SLC7A5PTGS1KDM4EUSP2EGFR
SCHEMBL28897405 0.84 SLC7A5 (0.49) SLC7A5PTGS1KDM4EUSP2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111494395-B Carbidopa and levodopa prodrugs and their use for treating parkinson's disease 艾伯维公司 2024-06-21 — — CN disclosed
CN-111454290-B Carbidopa and levodopa prodrugs and their use for treating parkinson's disease 艾伯维公司 2022-12-23 — — CN disclosed
CN-111362980-B Carbidopa and levodopa prodrugs and their use for treating parkinson's disease 艾伯维公司 2022-10-18 — — CN disclosed
CN-111494395-A Carbidopa and levodopa prodrugs and their use for treating parkinson's disease 艾伯维公司 2020-08-07 — — CN disclosed
CN-111454290-A Carbidopa and levodopa prodrugs and their use for treating parkinson's disease 艾伯维公司 2020-07-28 — — CN disclosed
CN-111362980-A Carbidopa and levodopa prodrugs and their use for treating parkinson's disease 艾伯维公司 2020-07-03 — — CN disclosed
EP-3569587-A1 INTERMEDIATES AND PROCESS FOR PREPARING L-DOPA DIPHOSPHATE AbbVie Inc. (US) 2019-11-20 — — EP disclosed
Send feedback